Skip to main content
Top
Published in: BMC Cancer 1/2021

01-12-2021 | Breast Cancer | Research article

Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes

Authors: Dooman Arefan, Ryan M. Hausler, Jules H. Sumkin, Min Sun, Shandong Wu

Published in: BMC Cancer | Issue 1/2021

Login to get access

Abstract

Background

The abundance of immune and stromal cells in the tumor microenvironment (TME) is informative of levels of inflammation, angiogenesis, and desmoplasia. Radiomics, an approach of extracting quantitative features from radiological imaging to characterize diseases, have been shown to predict molecular classification, cancer recurrence risk, and many other disease outcomes. However, the ability of radiomics methods to predict the abundance of various cell types in the TME remains unclear. In this study, we employed a radio-genomics approach and machine learning models to predict the infiltration of 10 cell types in breast cancer lesions utilizing radiomic features extracted from breast Dynamic Contrast Enhanced Magnetic Resonance Imaging.

Methods

We performed a retrospective study utilizing 73 patients from two independent institutions with imaging and gene expression data provided by The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA), respectively. A set of 199 radiomic features including shape-based, morphological, texture, and kinetic characteristics were extracted from the lesion volumes. To capture one-to-one relationships between radiomic features and cell type abundance, we performed linear regression on each radiomic feature/cell type abundance combination. Each regression model was tested for statistical significance. In addition, multivariate models were built for the cell type infiltration status (i.e. “high” vs “low”) prediction. A feature selection process via Recursive Feature Elimination was applied to the radiomic features on the training set. The classification models took the form of a binary logistic extreme gradient boosting framework. Two evaluation methods including leave-one-out cross validation and external independent test, were used for radiomic model learning and testing. The models’ performance was measured via area under the receiver operating characteristic curve (AUC).

Results

Univariate relationships were identified between a set of radiomic features and the abundance of fibroblasts. Multivariate models yielded leave-one-out cross validation AUCs ranging from 0.5 to 0.83, and independent test AUCs ranging from 0.5 to 0.68 for the multiple cell type invasion predictions.

Conclusions

On two independent breast cancer cohorts, breast MRI-derived radiomics are associated with the tumor’s microenvironment in terms of the abundance of several cell types. Further evaluation with larger cohorts is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Becht E, et al. Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers. Adv Immunol. 2016;130:95–190.CrossRefPubMed Becht E, et al. Immune contexture, immunoscore, and malignant cell molecular subgroups for prognostic and theranostic classifications of cancers. Adv Immunol. 2016;130:95–190.CrossRefPubMed
3.
go back to reference Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep. 2005;14(2):425–31.PubMed Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep. 2005;14(2):425–31.PubMed
4.
go back to reference Li, Hui, et al. “Quantitative MRI Radiomics in the Prediction of Molecular Classifications of Breast Cancer Subtypes in the TCGA/TCIA Data Set.” Nature News, Nature Publishing Group, 2016. Li, Hui, et al. “Quantitative MRI Radiomics in the Prediction of Molecular Classifications of Breast Cancer Subtypes in the TCGA/TCIA Data Set.” Nature News, Nature Publishing Group, 2016.
10.
go back to reference Braman NM, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57.CrossRefPubMedPubMedCentral Braman NM, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017;19(1):57.CrossRefPubMedPubMedCentral
13.
go back to reference Morris E, Burnside E, Whitman G, Zuley M, Bonaccio E, Ganott M, et al. Using computer-extracted image phenotypes from tumors on breast MRI to predict stage. The Cancer Imaging Archive; 2014. Morris E, Burnside E, Whitman G, Zuley M, Bonaccio E, Ganott M, et al. Using computer-extracted image phenotypes from tumors on breast MRI to predict stage. The Cancer Imaging Archive; 2014.
18.
go back to reference Kuhn, Max. "Variable selection using the caret package." URL http://cran. cermin. lipi. go. id/web/packages/caret/vignettes/caretSelection. pdf (2012). Kuhn, Max. "Variable selection using the caret package." URL http://​cran.​ cermin. lipi. go. id/web/packages/caret/vignettes/caretSelection. pdf (2012).
19.
go back to reference Chen T, Guestrin C. "Xgboost: A scalable tree boosting system." Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. ACM; 2016.CrossRef Chen T, Guestrin C. "Xgboost: A scalable tree boosting system." Proceedings of the 22nd acm sigkdd international conference on knowledge discovery and data mining. ACM; 2016.CrossRef
21.
go back to reference Sun, Roger, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180–91. Sun, Roger, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180–91.
Metadata
Title
Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes
Authors
Dooman Arefan
Ryan M. Hausler
Jules H. Sumkin
Min Sun
Shandong Wu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-021-08122-x

Other articles of this Issue 1/2021

BMC Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine